Battling Non-Small Cell Lung Carcinoma: Applying Biomarkers Testing to Pick the Best Immune Checkpoint Inhibitors Therapy
Bibliographic record
Abstract
Immune checkpoint inhibitors is a new treatment for Non-Small Cell Lung Carcinoma. Benefit from such ICI therapy, however, have been enjoyed by a minority of NSCLC patients, and durable clinical outcomes are scarce. Thus, identifying reliable biomarkers to predict patients’ possible response, and to indicate the progression status of tumors to further refine ICIs’ application in treating NSCLCs is of decisive importance. However, as ICIs are novel therapies applied for only a decade, long-term post-treatment follow-ups are scant, and the probing or detection methods for biomarkers may not be as reliable as believed. Thus, many of the biomarkers require further investigations to elucidate their exact role in varying NSCLC microenvironments. Based on previously established results and integrating updated clinical data, this review lists the 2 currently accepted ICI therapeutic regimens, presents their respective mechanisms of action and their corresponding predictive or prognostic biomarkers currently available. This systematic categorization of biomarkers to respective therapies may inform clinicians about the use of ICI therapies and raise their attention to emerging and established biomarkers in new treatment strategies.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.002 | 0.003 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.002 | 0.001 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.000 | 0.000 |
| Scholarly communication | 0.002 | 0.002 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.001 | 0.002 |
| Insufficient payload (model declined to judge) | 0.001 | 0.001 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".